NanoThea Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Out of Business

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Out of Business

NanoThea General Information

Description

Developer of a tumor-targeting delivery system designed to offer precise diagnostics and early cancer detection. The company's system focuses on safe polymer nanocarriers, nanoparticles accumulate inside tumor tissue due to improved permeation and retention through the leaky blood vessels, and confirm non-toxicity and biocompatibility, enabling doctors to get a precise tool for prostate cancer PET diagnostics and focal brachytherapy.

Contact Information

Website
www.nanothea.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Rakowiecka 36
  • Warsaw, 02-532
  • Poland
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Nanotechnology, Life Sciences, Oncology
Corporate Office
  • Rakowiecka 36
  • Warsaw, 02-532
  • Poland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NanoThea Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 08-Apr-2026 Completed Out of Business
2. Secondary Transaction - Private Completed Generating Revenue
1. Early Stage VC 01-Sep-2015 Completed Generating Revenue
To view NanoThea’s complete valuation and funding history, request access »

NanoThea Patents

  • 4

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 2

    Pending

  • Expiring in next 12 mo

NanoThea Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3133171-A1 Process of preparing polymeric nanoparticles that chelate radioactive isotopes and have a surface modified with specific molecules targeting the psma receptor and their use Pending 19-Mar-2019
EP-3941534-A1 Process of preparing polymeric nanoparticles that chelate radioactive isotopes and have a surface modified with specific molecules targeting the psma receptor and their use Pending 19-Mar-2019
US-20220152231-A1 Process of preparing polymeric nanoparticles that chelate radioactive isotopes and have a surface modified with specific molecules targeting the psma receptor and their use Inactive 19-Mar-2019
WO-2020188318-A1 Process of preparing polymeric nanoparticles that chelate radioactive isotopes and have a surface modified with specific molecules targeting the psma receptor and their use Inactive 19-Mar-2019 A61K51/1244

NanoThea Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

NanoThea FAQs

  • When was NanoThea founded?

    NanoThea was founded in 2014.

  • Where is NanoThea headquartered?

    NanoThea is headquartered in Warsaw, Poland.

  • What is the size of NanoThea?

    NanoThea has 2 total employees.

  • What industry is NanoThea in?

    NanoThea’s primary industry is Biotechnology.

  • Is NanoThea a private or public company?

    NanoThea is a Private company.

  • What is NanoThea’s current revenue?

    The current revenue for NanoThea is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process